MONTREAL, QUEBEC--(CCNMatthews - Dec. 21, 2006) - In light of recent market activity, Ecopia BioSciences Inc., (TSX:EIA) ("Ecopia" or the "Company"), has been requested by Market Regulation Services Inc., on behalf of the Toronto Stock Exchange, to comment thereon. First, the Company confirms that the clinical advancement of Ecopia's first anticancer compound, ECO-4601, is progressing steadily.
